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Histological Chorioamnionitis 
Induces Differential Gene 
expression in Human Cord Blood 
Mononuclear Leukocytes from term 
Neonates
suhita Gayen nee’ Betal1, swati Murthy1, Michael Favara1, Gina Fong1, Joanna s. Y. Chan2, 
sankar Addya3, thomas H. Shaffer1, Jay Greenspan1, Vineet Bhandari  4, Irfan Rahman  5 & 
Zubair H. Aghai1
Histological chorioamnionitis (HCA) is an infection of fetal membranes and complicates 5.2% to 28.5% 
of all live births. HCA is associated with increased mortality and morbidity in both premature and term 
neonates. exposure to HCA may have long-term consequences, including an increased risk for allergic 
disorders and asthma later in childhood, the mechanism(s) of which are still not yet well understood. 
the objective of this study was to determine the mRNA transcriptome of cord blood mononuclear 
leukocytes from term neonates to identify key genes and pathways involved in HCA. We found 366 
differentially expressed probe IDs with exposure to HCA (198 upregulated, 168 downregulated). These 
transcriptomes included novel genes and pathways associated with exposure to HCA. The differential 
gene expression included key genes regulating inflammatory, immune, respiratory and neurological 
pathways, which may contribute to disorders in those pathways in neonates exposed to HCA. our data 
may lead to understanding of the role of key genes and pathways identified on the long-term sequelae 
related to exposure to HCA, as well as to identifying potential markers and therapies to prevent HCA-
associated complications.
Chorioamnionitis (CA) is an infection of the fetal membranes and placenta that complicates 5.2% of all live 
births1. The prevalence of histological CA (HCA) in term neonates with spontaneous labor is 23.6–28.7%2,3. 
Approximately 500,000 to one million infants in the United States are born each year to mothers diagnosed with 
HCA. Exposure to HCA may have long-term consequences, including an increased risk for allergic disorders 
and asthma later in childhood4–6. Additionally, studies have demonstrated that exposure to HCA can also lead 
to developmental delay and cerebral palsy in preterm and term infants7–9. Asthma and other allergic chronic 
diseases during childhood affect greater than 7 million children in the United States10. Although HCA is associ-
ated with the development of asthma, allergic disorders, and neurodevelopmental impairment, the exact mecha-
nism for these complications is unknown. Exposure to infection during late fetal life is likely to incite epigenetic 
changes, which may modulate the immune and neurological systems and increase the risk for development of 
neurological and allergic disorders later in life.
Gene expression studies of cells and tissues have become a major tool for discovery in the pathogenesis of var-
ious diseases. Global gene expression by transcriptomic analysis can uncover gene signatures and help delineate 
molecular pathways involved in the development of asthma, allergy, and neurodevelopmental impairment in neo-
nates born to mothers with HCA. Previous studies have reported differential gene expression patterns associated 
1Neonatology, Thomas Jefferson University/Nemours, Philadelphia, PA, USA. 2Department of Pathology, Thomas 
Jefferson University, Philadelphia, PA, USA. 3cancer Genomics and Bioinformatics Laboratory, Sidney Kimmel 
Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. 4Section of neonatology, Department of 
Pediatrics, St. Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, PA, USA. 
5Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, United States. 
Correspondence and requests for materials should be addressed to Z.H.A. (email: zaghai@nemours.org)
Received: 9 October 2018
Accepted: 21 March 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:5862  | https://doi.org/10.1038/s41598-019-42205-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
with preterm labor and lipopolysaccharide (LPS) stimulation of cord blood leukocytes11,12. More recently, differ-
ential gene expression in whole blood from preterm neonates exposed to HCA has been published13. However, 
fetal inflammatory and immune response to microbial infection differ between preterm (born before 37 weeks 
gestation) and term infants14–16. The effects of HCA on gene expression profile on cord blood mononuclear leuko-
cytes in human term neonates have not been characterized. Our objective was to determine the mRNA transcrip-
tome of cord blood mononuclear leukocytes from term neonates and identify key genes and pathways involved 
in HCA.
Results
Ten term infants were enrolled in the study. Five infants had histological chorioamnionitis (HCA group), and five 
infants with no evidence of histological chorioamnionitis on placental histopathology served as the control group.
Differential Gene Expression. Comparison of the HCA group array data with the control group using 
transcriptome array console software revealed that 366 probe IDs were differentially expressed with a fold 
change ≥ 1.5 (p < 0.05). Of these, 198 probe IDs were significantly up-regulated (Supplementary Table 1), 60 
with annotated genes and 138 non-annotated genes. One hundred and sixty-eight probe IDs were significantly 
down-regulated (Supplementary Table 2), of which 105 had annotation with gene symbols and 63 were not anno-
tated. The top 10 up- and down-regulated genes based on the fold change are reported in Table 1. The top 10 
up-regulated genes included chemokine (C-C motif) receptor-2 (CCR2), a pro-inflammatory chemokine impor-
tant in inflammatory diseases including asthma17,18. The top down-regulated genes included two important anti-
microbial proteins, lactoferrin (LTF) and cathelicidin antimicrobial peptide (CAMP).
Differential Gene Expressions Related to Immune Response. Thirty genes related to immune 
response and important for regulation of inflammatory pathways were identified (Table 2). Twelve genes were 
up-regulated and 18 genes were down-regulated. The up-regulated genes have been previously associated with 
asthma; hyper-reactivity and allergy (CCR2, HRH2, PTEN); lung development and apoptosis (CHRNA7, 
RTKN2); and immune function (GIMAP4, GIMAP7, KLRC3 and CD99) (Table 3). Similarly, the down-regulated 
genes have roles in asthma and airway modeling (PTGS2, AREG, HBEGF, PLAUR, CAMP, LTF, FCAR, 
PDE4B, ZNF331 and IRAK2) and immune function (NR4A3, NFIL3, ADGRE3, TARM1 and ZC3H12A). The 
down-regulated gene CXCL1 has a role in lung development and BPD (Table 4).
Ingenuity pathway Analysis. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) 
software (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by loading 
366 probe sets that were differentially expressed with HCA19. Seventy-three functions were modified by differen-
tial gene expression with exposure to HCA. Important functions modified with the exposure to HCA are listed 
in Table 5. The modification of functions with HCA included genes related to immune system, inflammatory 
response, connective tissue disorders, neurodevelopmental disorders, hematological development and disorders, 
and respiratory development and disorders. Ingenuity Canonical Pathway Analysis identified 207 pathways that 
ProbeID Gene Symbol
HCA Group  
Average Expression
Control Group 
Average Expression
Fold 
Change Up/Down P-value
TC17001604.hg.1 LRRC37A4P 1389.16 344.89 4.01
Up
0.0245
TC04002938.hg.1 LOC285505 364.56 136.24 2.68 0.012
TC07000288.hg.1 LINC01061 1652 643.59 2.58 0.0117
TC03000255.hg.1 CCR2 765.36 304.44 2.51 0.0417
TC04001682.hg.1 FAM198B 643.59 256 2.5 0.0167
TC17000604.hg.1 LRRC37A2 13216.02 5556.65 2.37 0.0312
TC07001299.hg.1 TRGV4 140.07 60.13 2.32 0.0002
TC07001300.hg.1 TRGV3 179.77 79.89 2.24 4.50xE-05
TC04002939.hg.1 TMEM144 240.52 112.99 2.12 0.0173
TC17001603.hg.1 LRRC37A4P; LRRC37A2 20594.91 9946.68 2.08 0.0478
TC01003638.hg.1 PTGS2 252.48 9089.59 −35.91
Down
0.0205
TC04002953.hg.1 AREG 313 1884.54 −6.03 0.001
TC01001749.hg.1 G0S2 2352.53 13034.07 −5.54 0.008
TC05001854.hg.1 HBEGF 385.34 2005.85 −5.18 0.0022
TC19001593.hg.1 PLAUR 1448.15 7082.29 −4.89 0.0138
TC21001069.hg.1 SAMSN1 3956.48 17438.64 −4.42 0.0257
TC12001216.hg.1 OLR1 178.53 765.36 −4.27 0.0365
TC03000276.hg.1 CAMP 657.11 2683.69 −4.09 0.0011
TC09000508.hg.1 NR4A3 143.01 580.04 −4.07 0.0128
TC03001357.hg.1 LTF 2683.69 9345.14 −3.49 0.0208
Table 1. Top 10 differentially up- or down-regulated genes after exposure to HCA.
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were modified after exposure to HCA, of which 19 pathways are known to be important in immune regulation 
and inflammatory responses (Table 6).
IpA Networks. IPA picked up important networks related to immune, inflammatory, and neurological path-
ways. Four were closely related to immune modulation and inflammatory response and two were related to neu-
rologic disease. Networks 1 through 4 are shown in Fig. 1. Network 1 is related to humoral immune response, 
protein synthesis, cellular function and maintenance. Network 2 is related to post-translational modification, 
cellular development, connective tissue development and function. Network 3 is related to cellular movement, cell 
cycle, connective tissue development, and function. Network 4 is related to cellular movement, hematological sys-
tem development and function, and hematopoiesis. Networks 5 and 6 are closely related to neurological disease 
(Fig. 2). Network 5 involves organismal injury and abnormalities, reproductive system disease, and neurological 
disease. Network 6 involves dermatological diseases and conditions, organismal injury and abnormalities, as well 
as neurological disease.
Quantitative Real Time PCR Verification. To confirm gene expression results, we selected seven genes 
from the differentially expressed gene list that were closely related to inflammatory response and immune mod-
ulation. A quantitative Real-Time PCR was performed using total RNA to validate the microarray data from the 
same neonates studied by microarray analysis (Fig. 3). Of the seven selected differentially expressed genes, five 
were down-regulated (GOS2, AREG, HBEGF, CAMP and LTF) and two were up-regulated (VNN2 and TRGV3). 
Fold-changes obtained by RT-PCR were consistent with microarray results. All fold changes in RT-PCR results 
reached significance (p ≤ 0.05) except for TRGV3 (p = 0.24). A comparison of the microarray data with RT-PCR 
results is shown in Table 7.
Gene Symbol Up/Down Fold Change P-value
HCA Group 
Average Expression
Control Group 
Average Expression
CCR2
Up-regulated Genes
2.51 0.0417 765.36 304.44
TRGV4 2.32 0.0002 140.07 60.13
GIMAP4 2.29 0.0118 52498.92 23010.42
TRGV3 2.24 0.000045 179.77 79.89
KLRC3 1.8 0.0433 1458.23 809.00
HRH2 1.74 0.0233 1734.13 1002.93
CHRNA7 1.61 0.0201 33.36 20.68
GIMAP7 1.61 0.0086 4482.23 2778.33
RTKN2 1.59 0.0294 153.28 96.34
CD99 1.56 0.0121 2646.74 1698.45
PTEN 1.55 0.0275 694.58 448.82
GIMAP1-
GIMAP5; 
GIMAP5; 
GIMAP1
1.53 0.0155 989.12 648.07
PTGS2
Down-regulated Genes
−35.91 0.0205 252.48 9089.59
AREG −6.03 0.001 313.00 1884.54
HBEGF −5.18 0.0022 385.34 2005.85
PLAUR −4.89 0.0138 1448.15 7082.29
CAMP −4.09 0.0011 657.11 2683.69
NR4A3 −4.07 0.0128 143.01 580.04
LTF −3.49 0.0208 2683.69 9345.14
NFIL3 −2.77 0.0262 1192.69 3304.00
FCAR −2.35 0.0023 2256.70 5330.30
PDE4B −2.33 0.0125 280.14 652.58
ADGRE3 −2.3 0.042 680.29 1573.76
CXCL1 −2.05 0.0404 112.21 229.13
TARM1 −2.02 0.0059 116.16 235.57
SNAI1 −1.93 0.0083 47.18 91.14
ZNF331 −1.77 0.0308 288.01 512.00
ZC3H12A −1.76 0.0422 256.00 451.94
IRAK2 −1.74 0.048 164.28 284.05
NFKBIE −1.59 0.0351 413.00 657.11
Table 2. Differential expression of genes related to immune response after exposure to HCA.
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Discussion
Histological chorioamnionitis is associated with significant long-term morbidities including asthma and allergic 
and neurological disorders in preterm and term infants4–9. The exact mechanism of increased risk for asthma 
and allergic disorders in neonates born to mothers with HCA is not well understood. Inflammatory mediators 
released with HCA may reprogram the developing immune, respiratory, and neurological systems, leading to 
allergy, asthma, and immunological and neurological disorders20,21. To our knowledge, this is the first study 
reporting the differential gene expression profile in cord blood mononuclear leukocytes in term infants exposed 
to HCA. Our data indicate that the key genes regulating inflammatory, immune, respiratory, and neurological 
pathways are differentially expressed in cord blood leukocytes from term infants born to mothers with HCA.
Based on fold change, the top up-regulated genes included chemokine receptor CCR2, T-cell receptor gamma 
variable-3 (TRGV3), and TRGV4. CCR2 is an important chemokine receptor that induces macrophage and 
monocytes recruitment to sites of inflammation22. CCR2 is up-regulated on T-helper cells in an animal model of 
allergic asthma and blocking of CCR2 suppressed airway inflammation18.The top down-regulated genes included 
Gene Symbol Gene name Function
CCR2
C-C Motif Chemokine Receptor 
2, Receptor for monocyte 
chemoattractant protein-1
Role in asthma, inflammation
GIMAP4 GTPase, Immunity-Associated Protein family member 4 T- and B-cell development and survival, T-cell apoptosis
KLRC3 Killer Cell Lectin-Like Receptor Subfamily C, Member 3 Natural Killer receptor gene, role in cell proliferation
TRGV3 T Cell Receptor Gamma Variable 3 Peptide antigen binding, immune response
HRH2 Histamine Receptor H2 Histamine receptor gene, role in hypersensitiviy
CHRNA7 Cholinergic Receptor Nicotinic Alpha 7 Subunit Alter airway morphometry and lung function
GIMAP7 GTPase, Immune-Associated Nucleotide-Binding Protein 7
Regulators of lymphocyte survival and homeostasis 
(Schwefel D 2013)
RTKN2 Rhotekin 2 Role in apoptosis
CD99 Cluster of differentiation 99, Single-chain type-1 glycoprotein
Role in cell adhesion, migration, death, differentiation 
and diapedesis, and it influences processes associated 
with inflammation, immune responses (pasello M 2018)
VNN2 Vanin 2 Hematopoietic cell trafficking, Role in oxidative-stress
PTEN Phosphatase And Tensin Homolog Role in asthma, hyper-reactivity
Table 3. Up-regulated genes after exposure to HCA and their functions.
Gene 
symbol Gene name Function
PTGS2 Prostaglandin-Endoperoxide Synthase 2 Role in asthma and lung inflammation, hyperoxia induced lung injury
GOS2 G0/G1 Switch 2 Regulation of lipid metabolism
AREG Amphiregulin, Colorectum Cell-Derived Growth Factor Role in asthma, airway modelling, BPD
HBEGF Heparin-Binding Epidermal Growth Factor Role in asthma, airway modelling
PLAUR Plasminogen Activator, Urokinase Receptor Role in asthma, COPD
CAMP Cathelicidin Antimicrobial Peptide Role in asthma, lung infection
NR4A3 Nuclear Receptor Subfamily 4 Group A Member 3 Regulates neutrolphils number and survival, Treg cell development through activation of Foxp3
LTF Lactotransferrin Role in asthma, BPA VAP
FCAR Fc Fragment Of Immunoglobulin Alpha Receptor SNP associated with allergic asthma (Jasek M 2004)
NFIL3 Nuclear Factor, Interleukin 3 Regulated Critical regulator for IgE production and airway hyper-responsiveness.
PDE4B Phosphodiesterase 4B Role in asthma, inhibitors use as treatment
ADGRE3 Adhesion G Protein-Coupled Receptor E3 Modulator of immune cell funtion
CXCL1 C-X-C Motif Chemokine Ligand 1 Role in BPD, lung alveolization
TARM1 T Cell-Interacting, Activating Receptor On Myeloid Cells 1 Upregulated by LPS, recruitment to site of inflammation
SNAI1 Snail Family Transcriptional Repressor 1 Β-catenin target gene, lung fibrosis
ZNF331 Zinc Finger Protein 331 Pathogenesis of asthma
ZC3H12A Zinc Finger CCCH-Type Containing 12A Regulates the development and function of IL-5-producing TH2 cells through the Notch/Gata3 pathway
IRAK2 Interleukin 1 Receptor Associated Kinase 2 IRAK2 Attenuate the Proinflammatory Effects of IL-33 in Asthma-like Mouse Models.
Table 4. Down-regulated genes after exposure to HCA and their functions.
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HBEGF, LTF, CAMP, and NR4A3. HBEGF is a potent vasodilator of intestinal microvasculature, and supplemen-
tation of HBEGF reduced intestinal injury in animal models of necrotizing enterocolitis (NEC)23–25.
In utero exposure to HCA leads to fetal inflammatory response syndrome. Understanding the effects of the 
fetal inflammatory response on the programming of immune, respiratory, and neurological systems in neonates 
could lead to new ways of modulating these responses and improving long-term consequences. We have iden-
tified several key genes involved in immune function, inflammation, and lung development that are expressed 
differentially after exposure to HCA. These candidate genes are likely to play a critical role in long-term conse-
quences including bronchopulmonary dysplasia (BPD), asthma, allergy, and immunological disorders in neo-
nates exposed to HCA. This warrants further functional investigation.
We report that several important genes involved in the immune system are up-regulated in cord blood mon-
onuclear cells after exposure to HCA. RTKN2 has anti-apoptotic properties, is highly expressed in T-cells, and 
plays a role as a key signaling switch for regulation of genes involved in T-cell survival26. RTKN2 may prolong 
survival of inflammatory cells and contribute to an exaggerated inflammatory response in neonates exposed to 
HCA. CD99 is a cell surface protein involved in cell adhesion, migration, differentiation, and apoptosis, and influ-
ences processes associated with inflammation and immune response27. GIMAP family members play a role in 
T-helper cell differentiation28. GIMAP4 and GIMAP5 have a role in T-cell survival. GIMAP7 is also a regulator of 
lymphocyte survival and homeostasis29. NR4A3, a gene involved in protein coding that regulates Treg cell devel-
opment through activation of FoxP3, and which may have potential for therapeutic target for immune disorders, 
was down-regulated30. NR4A3 also positively regulates neutrophil survival and homeostasis31.
Our data indicate that several key pro-inflammatory mediators are down-regulated in cord blood mono-
nuclear leukocytes after exposure to HCA. The down-regulation of a few pro-inflammatory mediators likely 
is a modulating mechanism for the exaggerated inflammatory response induced by HCA. The inflammatory 
mediators downregulated by HCA include PDE4B, CXCL1, TARM1, and IRAK2. PDE4B degrades cyclic AMP, 
a second messenger involved in inflammatory process. Selective inhibition of PDE4B is a therapeutic target for 
inflammatory and allergic disorders32. CXCL1 is a potent neutrophil chemoattractant that plays a role in the 
Modified Functions
Number of Genes 
Involved
Range of p-value 
for genes involved
Cellular Movement 46 1.26E-13-1.52E-03
Immune Cell Trafficking 38 1.26E-13-1.03E-03
Inflammatory Disease 46 7.43E-13-1.25E-03
Cell Death and Survival 60 1.5E-12-1.46E-03
Immunological Disease 47 2.74E-12-1.25E-03
Connective Tissue Disorders 38 3.3E-12-1.47E-03
Inflammatory Response 55 3.55E-11-1.38E-03
Neurological Disease 32 1.29E-10-1.38E-03
Cell-To-Cell Signaling and Interaction 40 3.45E-10-1.51E-03
Hematological System Development and Function 44 3.45E-10-1.51E-03
Cellular Growth and Proliferation 49 2.3E-07-1.46E-03
Hematopoiesis 27 4.16E-07-9.74E-04
Lymphoid Tissue Structure and Development 33 4.16E-07-9.74E-04
Cellular Function and Maintenance 42 4.95E-07-1.52E-03
Humoral Immune Response 15 5.54E-07-1.4E-03
Infectious Diseases 28 6.5E-07-1.39E-03
Respiratory Disease 19 6.5E-07-1.23E-03
Cell Cycle 26 6.84E-07-1.49E-03
Gene Expression 37 6.84E-07-1.5E-03
Free Radical Scavenging 14 7.69E-06-9.02E-06
Cell-mediated Immune Response 15 2.3E-05-5.63E-04
DNA Replication, Recombination, and Repair 11 1.06E-04-4.46E-04
Antimicrobial Response 9 2.39E-04-2.39E-04
Nervous System Development and Function 15 3.11E-04-1.19E-03
Post-Translational Modification 14 3.43E-04-3.43E-04
Hypersensitivity Response 5 3.8E-04-3.8E-04
Hematological Disease 39 4.13E-04-1.09E-03
Cellular Assembly and Organization 6 8.04E-04-8.04E-04
Psychological Disorders 3 9.59E-04-9.59E-04
Respiratory System Development and Function 2 9.59E-04-9.59E-04
Developmental Disorder 12 1.24E-03-1.24E-03
Behavior 17 1.47E-03-1.47E-03
Table 5. Functions modified with exposure to HCA.
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development of BPD33. IRAK2 forms a Myddosome complex with Myd88 and IRAK4, activating downstream 
NF-kB and MAPKs P38 and JNK, leading to inflammatory response34. The roles of these pro-inflammatory medi-
ators downregulated by exposure to HCA need further investigation.
We also report that several key genes involved in lung development, BPD, and asthma are expressed differentially 
in cord blood mononuclear cells after exposure to HCA. Exposure to HCA upregulates CHRNA7, a key mediator 
of the biological effects of nicotine. CHRNA7 plays a critical role in lung development as well in the pathogenesis of 
asthma35,36, and inhibition of CHRNA7 is an important therapeutic target for asthma36. Amphiregulin (AREG) is a 
member of the epidermal growth factor family and contributes to the regulation of cell proliferation. Recombinant 
AREG suppresses epithelial cell apoptosis in LPS-induced lung injury in mice37. Down-regulation of AREG by HCA 
may contribute to the development of BPD by increasing epithelial cell apoptosis. CAMP plays a critical role in 
innate immunity against invasive bacterial infections. CAMP is an important host defense against respiratory path-
ogens. Suppression of CAMP by HCA may increase the risk for recurrent respiratory infections in neonates exposed 
to HCA. Ramos-Martinez et al. showed that treatment with vitamin D reduced respiratory infections in patients 
with asthma, and this effect was mediated by increase in CAMP38. LTF is an important mucosal antimicrobial pro-
tein that is also downregulated in neonates exposed to HCA. Revenis showed that the level of LTF was lower in tra-
cheal aspirate samples from premature infants who developed BPD39. Additionally, LTF can down-regulate allergic 
airway inflammation in asthma40. In an animal model of allergic rhinitis, LTF administration in the nostril alleviated 
allergic rhinitis and its mechanisms41. NFIL3 is the most strongly induced transcription factor by IL-4 stimula-
tion and is a critical regulator of IgE production and airway hyper-responsiveness42,43. The target genes (SNAI1, 
ZNF331, Zc3h12a) for the canonical Wnt/B-catenin pathway are down-regulated after exposure to HCA. These 
target genes of Wnt/B-catenin pathways play a role in the pathogenesis of asthma44–46. Peng et al. demonstrated that 
Zc3h12a-knockout mice have severe spontaneous lung inflammation with an increase in IL-5- and IL-13-producing 
cells in the lung45. ZNF331 was expressed differentially in bronchial alveolar lavage cells from patients with asthma46. 
PTEN regulates airway smooth muscle contraction in allergic asthma47. Epithelial-mesenchymal transition (EMT) 
accounts for accumulation of subepithelial mesenchymal cells and contributes to airway hyper-responsiveness and 
remodeling48. Up-regulating expression of PTEN inhibits EMT and may be protective on airway modeling in asthma 
and BPD. PTGS2/COX2 increases lung inflammation and impairs lung development33,49. HBEGF overexpression is 
associated with airway remodeling and asthma50. Interestingly, we found that expression of PTGS2 and HBEGF was 
down-regulated in cord blood mononuclear cells after exposure to HCA. HBEGF was also downregulated in lung 
tissue after intra-amniotic LPS administration in an animal model of HCA51. The role of PTGS2 and HBEGF on lung 
development and lung inflammation needs further investigation.
Infants and children born to mothers with HCA are at not only an increased risk for development of inflamma-
tory, immune, and allergic diseases, but they are also predisposed to abnormal neurodevelopmental disorders7–9. 
Our pathway analysis indicates that exposure to HCA affects genes involved in nervous system development, 
neurological disease, behavioral, developmental, and psychological disorders. Allard et al. showed that female rats 
exposed to in utero placental inflammation showed hyperactive behavior after puberty52. IPA analysis of our data 
indicates that HCA differentially expressed genes in the IL-17 signaling pathway, IL-17A signaling in airway cells, 
and IL-17A signaling in fibroblasts. Recent findings suggests that IL-17A in the fetal and maternal inflammatory 
Ingenuity Canonical Pathways −log10(p-value) Molecules involved in pathways
Protein Kinase A Signaling 4.46 PTEN,PTGS2,PTPRE,DUSP6,MYH10, NFKBIE,PDE4B,ADD2,DUSP2,NFKBID
PI3K/AKT Signaling 3.32 PTEN,PTGS2,CDKN1A,NFKBIE,NFKBID
IL-17A Signaling in Airway Cells 3.12 PTEN,CXCL1,NFKBIE,NFKBID
MIF-mediated Glucocorticoid 
Regulation 3.09 PTGS2,NFKBIE,NFKBID
MIF Regulation of Innate Immunity 2.83 PTGS2,NFKBIE,NFKBID
iCOS-iCOSL Signaling in T Helper 
Cells 2.46 PTEN,HLA-DQB1,NFKBIE,NFKBID
TNFR2 Signaling 2 NFKBIE,NFKBID
IL-17 Signaling 1.99 PTGS2,CXCL1,TIMP1
4-1BB Signaling in T Lymphocytes 1.91 NFKBIE,NFKBID
IL-1 Signaling 1.9 NFKBIE,IRAK2,NFKBID
PPAR Signaling 1.9 PTGS2,NFKBIE,NFKBID
IL-17A Signaling in Fibroblasts 1.84 NFKBIE,NFKBID
B Cell Activating Factor Signaling 1.71 NFKBIE,NFKBID
IL-8 Signaling 1.7 HBEGF,PTGS2,CXCL1,IRAK2
p53 Signaling 1.68 PTEN,CDKN1A,TNFRSF10B
PI3K Signaling in B Lymphocytes 1.54 PTEN,NFKBIE,NFKBID
Glucocorticoid Receptor Signaling 1.49 CCNH,PTGS2,CDKN1A,NFKBIE,NFKBID
IL-10 Signaling 1.29 NFKBIE,NFKBID
T Helper Cell Differentiation 1.29 HLA-DQB1,IL23R
Table 6. Canonical pathways in ingenuity pathway analysis associated with differentially expressed genes 
between control and HCA groups.
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response leads to fetal brain injury and neurological sequelae including cerebral palsy and potentially autism, 
schizophrenia, and multiple sclerosis later in life53.
Our study has several strengths. This is the first study reporting differential gene expression in cord blood 
from term neonates exposed to HCA. A similar study reported differential gene expression after exposure to HCA 
in preterm infants using whole blood, which does not allow distinction of the relative contribution of leukocytes. 
Our study is unique as global gene expression was performed in cord blood mononuclear leukocytes, not in 
whole blood. Further, our global gene expression data were validated by Real-Time PCR for the identified target 
genes. Six out of seven genes validated with Real-Time PCR showed significant change in the same direction as 
microarray data, with the seventh gene displaying trends in the same direction. Neonates are vulnerable subjects, 
Figure 1. Ingenuity pathway analysis networks related to immune modulation and inflammatory response 
are presented in this figure (A–D). Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) 
software (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by 
loading 366 probe sets that were differentially expressed with HCA19.
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and drawing a large amount of blood from them is ethically unacceptable. By using umbilical cord blood, we were 
able to collect a large amount of blood non-invasively without additional risks to the neonates.
Our study also has several limitations. Our sample size of 10 neonates is small, but similar sample sizes have 
been used commonly in studies investigating differential gene expression using microarray12,54. There is an inher-
ent chance of finding differences in the gene expression due to multiple comparison; however, our results were 
validated by using Real-Time PCR.
In conclusion, HCA induces differential gene expression in cord blood mononuclear leukocytes from term 
neonates. We found novel genes and pathways associated with exposure to HCA, including key genes regulating 
inflammatory, immune, respiratory and neurological pathways. This differential gene expression may contribute to 
inflammatory, immunological, and neurological disorders in neonates exposed to HCA. Future studies can further 
validate differential expression of target genes in a larger cohort of neonates exposed to HCA. Our data may lead to 
understanding the role of key genes and pathways identified in this study on the long-term sequelae related to expo-
sure to HCA. Functional studies on the identified genes and pathways could lead to the development of potential 
markers for the diseases caused by exposure to HCA and possible therapy to prevent those complications.
Methods
ethical approval: human study protocol and institutional biosafety approvals. All human proto-
cols and procedures described in this study were approved by the Institutional Review Board of Thomas Jefferson 
University Hospital. All experiments performed in this study were approved and in accordance with the Nemours 
Institutional Biosafety Committee. The Institutional Review Board waived informed consent as this study was 
performed on discarded blood and placental tissue samples.
study Design. This is a prospective observational study that examines differential gene expression in mon-
onuclear leukocytes isolated from cord blood of term infants born to mothers with HCA. Cord blood and fetal 
membranes were collected from term neonates (37–40 weeks of gestation). Exclusion criteria were maternal 
infections other than HCA and complications of pregnancy including diabetes, hypertension, major congenital/
chromosomal anomalies, and intrauterine growth restriction.
Figure 2. Ingenuity pathway analysis networks related to neurological disease are presented in this figure 
(A,B). Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) software (QIAGEN Inc., 
https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by loading 366 probe sets that 
were differentially expressed with HCA19.
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Cord blood collection and isolation of leukocytes. At the time of delivery, the umbilical cord was 
disinfected and cut at the placental side of the clamp. Cord blood was collected in sterile EDTA tubes, mixed thor-
oughly, and checked for blood clots. Mononuclear leukocytes were isolated by Ficoll-Paque Plus density gradient 
(GE Healthcare Biosciences, Pittsburgh, PA), following the manufacturer’s protocol and the method of Normann 
et al.55. In brief, collected blood was diluted with an equal amount of phosphate buffered saline (PBS). 1 ml of 
PBS was mixed thoroughly with 16 ml of Ficoll-Paque plus and used as density gradient. 25 to 30 ml of diluted 
blood was layered on top of the Ficoll mixture and centrifuged at 400xg for 30 minutes. The upper plasma layer 
was collected and centrifuged to remove platelets. The cellular interface was then collected in a separate tube and 
washed with PBS containing 1 mM EDTA. Cells were washed with autologous plasma to remove platelets. Finally, 
the mononuclear leukocytes were washed with PBS, and 2 million packed cells per vial were saved at −80 °C for 
RNA isolation and microarray analysis.
Figure 3. Box plot for real-time PCR data on selected genes in the two groups (Control and HCA) are 
presented in this figure.
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Fetal membrane collection, processing, staining, and diagnosis of HCA. Small pieces of fetal 
membranes tissue were washed with cold PBS and fixed in 10% neutral buffered formalin for 24–48 hours. 
Membrane pieces were processed and paraffin embedded in Histoplast LP (Thermo Fisher Scientific, Fremont, 
CA). Samples were sectioned at 5 µm on a Leica RM2255 microtome (Leica, Buffalo Grove, IL) and floated onto 
Superfrost® Plus slides (Thermo Fisher Scientific, Fremont, CA). The sections were heat immobilized for 60 min-
utes at 60 °C and were subsequently equilibrated to room temperature prior to staining. The slides were placed on 
Tissue-Tek Prizma stainer (Sakura Finetek USA, Torrance, CA) and were deparaffinized with xylene, hydrated 
through a graded series of alcohols, and hydrated to water. Finally, the slides were stained with Harris hematoxy-
lin (BBC Biomedical, Mount Vernon, WA) and eosin (Acros Organics, Cole-Parmer, Vernon Hills, IL) and were 
dehydrated, cleared, and mounted in Permount® (Thermo Fisher Scientific, Fremont, CA). Tissue samples were 
processed by the Nemours Histochemistry and Tissue Processing Core using standard workflows and operating 
procedures. The stained slides were examined by a pathologist (JC) and classified either as HCA (placental mem-
branes score ≥ stage 1) or no HCA (no histological inflammatory changes in fetal membranes)56.
RNA Isolation and Gene Expression Study. Total RNA was isolated using Qiagen miRNeasy Mini Kit 
(Qiagen, Germantown, MD). RNA was quantified on a Nanodrop ND-2000 spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA), and quality was assessed by an Agilent 2200 TapeStation (Agilent Technologies, Palo 
Alto, CA). 100 ng of RNA was used from each sample to prepare fragmented biotin-labeled cDNA by GeneChip 
WT PLUS reagent kit (Affymetrix, Santa Clara, CA). The Affymetrix gene chips and Human Transcriptome Array 
2.0 were hybridized with 5 µg of fragmented biotin-labeled cDNA in 220 µl hybridization cocktail, followed by 
target denaturation at 99 °C for 5 min and then 45 °C for 5 min. Hybridization was performed for 16 hours at 45 °C 
with a rotation of 60 rpm. An Affymetrix GeneChip hybridization wash and stain kit was used to wash and stain 
the arrays in GeneChip Fluidic Station 450. Chips were scanned on an Affymetrix GeneChip Scanner 3000 using 
Command Console Software (Thermo Fisher Scientific, Waltham, MA). Expression Console Software v1.4.1 was 
used to perform quality control.
Real-time pCR. Selected genes from microarray data were validated by Quantitative Real Time PCR with 
TaqMan Gene Expression Assay Mix from Applied Biosystems (Applied Biosystems, Foster City, CA) following 
the manufacturer’s protocol. In brief, 200 ng of total RNA was reverse transcribed with a High-Capacity cDNA 
RT kit (Applied Biosystems, Foster City, CA) in a total reaction volume of 20 µl. Real-Time PCR was performed 
in duplicate wells with 0.5 µl of cDNA preparation using TaqMan Universal PCR Master Mix and TaqMan Gene 
Expression Assay mixes specific for different genes. Actin B was used as a housekeeping gene, and data were col-
lected by Quant Studio 12K Flex Thermal Cycler (Applied Biosystems, Foster City, CA).
statistical Analysis. Expression Console Software was used to generate a Chp file from Affymetrix after 
sst-rma normalization. The HCA Group was compared with the control group using Transcriptome array console 
software v 1.4.1 (Thermo Fisher Scientific, Waltham, MA). Genes with fold change ≥1.5 and p < 0.05 were iden-
tified as differentially expressed. Student t-test was performed for comparison of the two groups. Gene expres-
sion data are available at the Gene Expression Omnibus (GEO) database of the NIH under accession number 
GSE120855. Data were analyzed through the use of IPA (QIAGEN Inc., https://www.qiagenbioinformatics.com/
products/ingenuitypathway-analysis)19. Real-Time data were compared using Student t-test or Wilcoxon signed 
rank test between the HCA and control group.
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